Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-10-01 Sale | 2021-10-05 7:21 pm | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 1,251 | $14.21 | $17,783 | 70,888 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-05 Option Award | 2024-06-07 4:00 pm | N/A 2034-06-04 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 60,000 | $0 | 60,000 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 250,000 | $0 | 250,000 (Direct) | View |
2023-07-21 Option Award | 2023-07-25 12:31 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 113,000 | $0 | 113,000 (Direct) | View |
2023-02-16 Option Award | 2023-02-21 4:58 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 124,000 | $0 | 124,000 (Direct) | View |
2022-08-22 Tax Withholding | 2022-08-23 4:03 pm | N/A N/A | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 2,828 | $3.05 | 14,311 (Direct) | View |
2022-08-21 Exercise | 2022-08-23 4:03 pm | N/A N/A | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 6,667 | $0 | 14,311 (Direct) | View |
2022-02-09 Option Award | 2022-03-29 4:05 pm | N/A 2032-02-08 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 95,000 | $0 | 95,000 (Direct) | View |
2021-10-01 Exercise | 2021-10-05 7:21 pm | N/A N/A | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 1,251 | $7.5 | 70,888 (Direct) | View |
2021-08-23 Tax Withholding | 2021-10-05 7:21 pm | N/A N/A | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 1,961 | $0 | 70,888 (Direct) | View |
2021-08-23 Exercise | 2021-10-05 7:21 pm | N/A N/A | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 7,918 | $0 | 70,888 (Direct) | View |
2021-02-10 Option Award | 2021-02-12 5:43 pm | N/A 2031-02-09 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CFO | 70,000 | $0 | 70,000 (Direct) | View |
2020-08-24 Tax Withholding | 2020-08-25 4:12 pm | N/A N/A | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CFO | 1,900 | $0 | 104,100 (Direct) | View |
2020-08-21 Exercise | 2020-08-25 4:12 pm | N/A N/A | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CFO | 6,666 | $0 | 104,100 (Direct) | View |
2020-08-21 Option Award | 2020-08-25 4:12 pm | N/A 2030-08-21 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CFO | 85,000 | $0 | 104,100 (Direct) | View |
2020-02-05 Option Award | 2020-02-12 4:52 pm | N/A 2030-02-05 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann VP-Finance | 30,000 | $0 | 30,000 (Direct) | View |